Brief: Astrazeneca Pharma India Surrenders Manufacturing License
02/09/2025 13:46
Sept 2 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS: SURRENDERS MANUFACTURING LICENSE Source text: ID:nBSE3qVVyp Further company coverage: ASTR.NS ((Reutersbriefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan